These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1695173)

  • 1. Some haemostatic parameters in patients with deep and superficial venous thrombosis.
    Krupiński K; Bodzenta-Lukaszyk A; Lussa A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):173-8. PubMed ID: 1695173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XII, plasma prekallikrein, alpha 2-macroglobulin and C1-inhibitor levels in renal allograft recipients during immunosuppression with cyclosporin A--sequential measurements over four months in 17 patients.
    Lohri A; Huser B; Lämmle B; Oberholzer M; Thiel G; Duckert F
    Thromb Haemost; 1987 Dec; 58(4):993-7. PubMed ID: 2451306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between factor XII, von Willebrand factor and postoperative deep vein thrombosis.
    Nilsson T; Mellbring G; Hedner U
    Acta Chir Scand; 1986 May; 152():347-9. PubMed ID: 3090810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of coagulation proteins as acute-phase reactants in horses with colic.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):542-5. PubMed ID: 9582953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
    Gluszko P; Undas A; Amenta S; Szczeklik A; Schmaier AH
    J Lab Clin Med; 1994 Feb; 123(2):232-40. PubMed ID: 8301199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
    Kruse P; Lasson A; Hage E
    J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA; Alfaro MJ; Rocha E
    Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B; Tran TH; Ritz R; Duckert F
    Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives.
    Gordon EM; Ratnoff OD; Saito H; Donaldson VH; Pensky J; Jones PK
    J Lab Clin Med; 1980 Nov; 96(5):762-9. PubMed ID: 7419960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
    Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE
    J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and fibrinolysis after total hip replacement and their relations with deep vein thrombosis.
    Paramo JA; Rocha E
    Haemostasis; 1985; 15(5):345-52. PubMed ID: 3935549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK; Schmaier AH; Colman RW
    Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
    [No Abstract]   [Full Text] [Related]  

  • 18. [Haemostatic changes related to extracorporeal circulation (ECC) (author's transl)].
    Witzke G; Elert O
    Anaesthesist; 1981 Feb; 30(2):64-70. PubMed ID: 6164310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness.
    Speiser W; Mallek R; Koppensteiner R; Stümpflen A; Kapiotis S; Minar E; Ehringer H; Lechner K
    Thromb Haemost; 1990 Oct; 64(2):196-201. PubMed ID: 2125371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-mediated reactions of blood clotting and related phenomena.
    Ratnoff OD
    Nouv Rev Fr Hematol (1978); 1979; 21(1):75-9. PubMed ID: 158745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.